Viewing Study NCT05583604

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:19 PM
Ignite Modification Date: 2026-06-04 @ 9:06 PM
Study NCT ID: NCT05583604
Status: AVAILABLE
Last Update Posted: 2025-12-18
First Post: 2022-10-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Managed Access Programs for AIN457, Secukinumab
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hidradenitis Suppurativa (HS) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MAP View
None Manage Access Program View
None Hidradenitis suppurativa (HS) View
None AIN457 View
None secukinumab View
None Cosentyx View